ALFA Filings
Every announcement, straight from the exchange
Every Sat Kartar Life board meeting outcome announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements
Sat Kartar Life approved allotting equity shares and convertible warrants totaling ₹47.22 Crore. The company also appointed new secretarial and internal auditors for FY 2026-27.
Sat Kartar Life Limited's board approved raising ₹49.79 Crore through the preferential issuance of equity shares and convertible warrants to non-promoter investors. Additionally, the company will acquire the remaining 24% stake in Plantomed Neutraceuticals for ₹1.21 Crore to make it a wholly-owned subsidiary. An EGM is scheduled for May 13, 2026, to seek shareholder approval.
Sat Kartar Shopping Limited has scheduled a board meeting for April 18, 2026, to consider a fund-raising proposal via a preferential issue. The company's trading window for designated persons is closed from April 15 to April 20, 2026, in compliance with insider trading regulations.